BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16317707)

  • 1. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
    Pascale RM; Simile MM; Calvisi DF; Frau M; Muroni MR; Seddaiu MA; Daino L; Muntoni MD; De Miglio MR; Thorgeirsson SS; Feo F
    Hepatology; 2005 Dec; 42(6):1310-9. PubMed ID: 16317707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
    Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
    Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hsp90 co-chaperones Cdc37 and Sti1 interact physically and genetically.
    Abbas-Terki T; Briand PA; Donzé O; Picard D
    Biol Chem; 2002 Sep; 383(9):1335-42. PubMed ID: 12437126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp90 and Cdc37 -- a chaperone cancer conspiracy.
    Pearl LH
    Curr Opin Genet Dev; 2005 Feb; 15(1):55-61. PubMed ID: 15661534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
    Calvisi DF; Pinna F; Ladu S; Pellegrino R; Muroni MR; Simile MM; Frau M; Tomasi ML; De Miglio MR; Seddaiu MA; Daino L; Sanna V; Feo F; Pascale RM
    Carcinogenesis; 2008 Aug; 29(8):1639-47. PubMed ID: 18579559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat.
    De Miglio MR; Virdis P; Calvisi DF; Frau M; Muroni MR; Simile MM; Daino L; Careddu GM; Sanna-Passino E; Pascale RM; Feo F
    Cancer Res; 2006 Nov; 66(21):10384-90. PubMed ID: 17079458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
    De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
    Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells.
    Gray PJ; Stevenson MA; Calderwood SK
    Cancer Res; 2007 Dec; 67(24):11942-50. PubMed ID: 18089825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruptive cell cycle regulation involving epigenetic downregulation of Cdkn2a (p16(Ink4a)) in early-stage liver tumor-promotion facilitating liver cell regeneration in rats.
    Tsuchiya T; Wang L; Yafune A; Kimura M; Ohishi T; Suzuki K; Mitsumori K; Shibutani M
    Toxicology; 2012 Sep; 299(2-3):146-54. PubMed ID: 22659510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
    Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
    Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.
    Feo F; Frau M; Tomasi ML; Brozzetti S; Pascale RM
    Exp Biol Med (Maywood); 2009 Jul; 234(7):726-36. PubMed ID: 19429855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation.
    Fujino T; Takeuchi A; Maruko-Ohtake A; Ohtake Y; Satoh J; Kobayashi T; Tanaka T; Ito H; Sakamaki R; Kashimura R; Ando K; Nishimaki-Mogami T; Ohkubo Y; Kitamura N; Sato R; Kikugawa K; Hayakawa M
    J Biochem; 2012 Dec; 152(6):577-86. PubMed ID: 22969091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdc37 enhances proliferation and is necessary for normal human prostate epithelial cell survival.
    Schwarze SR; Fu VX; Jarrard DF
    Cancer Res; 2003 Aug; 63(15):4614-9. PubMed ID: 12907640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition.
    Feo F; De Miglio MR; Simile MM; Muroni MR; Calvisi DF; Frau M; Pascale RM
    Biochim Biophys Acta; 2006 Apr; 1765(2):126-47. PubMed ID: 16216419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk2: a genuine protein kinase client of Hsp90 and Cdc37.
    Prince T; Sun L; Matts RL
    Biochemistry; 2005 Nov; 44(46):15287-95. PubMed ID: 16285732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer.
    Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T
    Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication.
    Zannetti C; Mondini M; De Andrea M; Caposio P; Hara E; Peters G; Gribaudo G; Gariglio M; Landolfo S
    Virology; 2006 May; 349(1):79-86. PubMed ID: 16504234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
    Bastide K; Guilly MN; Bernaudin JF; Joubert C; Lectard B; Levalois C; Malfoy B; Chevillard S
    Lung Cancer; 2009 Mar; 63(3):348-53. PubMed ID: 18656278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System.
    Hallett ST; Pastok MW; Morgan RML; Wittner A; Blundell KLIM; Felletar I; Wedge SR; Prodromou C; Noble MEM; Pearl LH; Endicott JA
    Cell Rep; 2017 Oct; 21(5):1386-1398. PubMed ID: 29091774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.